March 10th, 2010 • Human Genetics • No Comments »
Practice Fusion:
You get $44,000 for using an EHR,
Practice Fusion is entirely free.
Do the math.
Ok.
Lie: You get $44,000 for using an EHR
Fact: [ARRA § 4101] If an “eligible professional” is a yet-undefined “meaningful EHR user,” they could quality for Medicare and Medicaid “incentives” of “an amount equal to 75 percent of the allowed charges under this part for all such covered professional services furnished by the eligible professional during such year” from the to-be-established “Federal Supplementary Medical Insurance Trust Fund” not exceeding:
- 2011: $15,000
- 2012: $12,000
- 2013: $8,000
- 2014: $4,000
- 2015: $2,000
- 2016: $0
Then, Medicare and Medicaid will penalize you up to 5% by the end of the decade from their rates which are already the lowest in the industry —unless you can prove to them why they shouldn’t. You probably won’t.
Commentary:
There is no $44,000.
Maybe you can apply for a few extra thousand dollars in medicare disbursements over several years if you are particularly sophisticated and already participate in Medicare or Medicaid.
Most practices will lose significant gross revenue from HITECH penalties by default.
Anybody who says otherwise is trying to sell you something dubious —probably more consulting to buy more consulting about how to save money through hiring consultants.
If $15,000 in 2011 is enough to matter to your practice, you are either a clueless medical student or about to go out of business.

March 9th, 2010 • Genetic Medicine • No Comments »
It has been one year since I commented on 23andMe’s foray into clinical medicine. I was frankly blown away that such a move would be so blatant without integration of health care practitioners.
I also was blown away that Myriad wouldn’t sue the ever living bejesus out of 23andMe. A year later, no lawsuit. I am still surprised about this one. Don’t you have to demonstrate protection of your patent to keep it?
Maybe Google/23andMe are paying a VIG to Myriad? I don’t know, but it hasn’t shown up on Myriad’s SEC reports yet……
Why was I so surprised? Well, a few months after 23andMe launched the service AND Myriad did not sue, MYRIAD WAS SUED.
I began to wonder if not suing Google/23andMe was a sign of weakness. I was certain Myriad would then shut down the DTC Genomics BRCA testing.
To date, they have not.
This begs the question, does Myriad think they do not have a case and would lose against Google, thus strengthening the case against them by the ACLU? If that is truly the case and we will begin to see judicial activism in patent removal, well, then we could be in for an EXPLOSION of genetic testing labs out there, each doing their own thing, their own way.
An article in Nature Medicine by Brendan Borrell, does an excellent job of discussion the potential backlash and issues related to DTC Genomics and patent holders. Balaji S. of Counsyl took the tech line. “Should we really be charge to look in the mirror?” Well, Balaji, do you have to buy a mirror to look in it? FAIL
The question is: “Will other patent holders see themselves as vulnerable by allowing DTC Genomics companies to test for THEIR patented genetic markers?”
This could prompt a huge wave of lawsuits against these fledgling DTC Genomics companies. Normally, companies sue to shake down, scare away competition and make money or at least protect patents. What we could see is lawsuits designed to crush these young companies in an attempt to scare off the ACLU et.al.
By Myriad NOT suing 23andMe, we may have opened up a new wave of patent paranoia and fear. When that happens companies often turn to the courts to scare away competitors and people hell bent on their (patent) destruction……(ACLU)
It will be interesting to see what this year holds for the Gene Patent……